AffiAB® Goat anti-NSP15 (SARS-CoV-2) Polyclonal IgG Antibody

The AffiAB® Goat anti-NSP15 (SARS-CoV-2) Polyclonal IgG Antibody is an antibody specifically designed to target and detect the NSP15 protein of the SARS-CoV-2 virus. NSP15, also known as endoribonuclease, is an important enzyme involved in viral replication and evasion of the host immune response.

This polyclonal antibody is produced by immunizing goats with purified NSP15 protein or a specific peptide sequence derived from NSP15. The resulting antibody is then purified from goat serum using various purification techniques to ensure high specificity and quality.

The AffiAB® Goat anti-NSP15 (SARS-CoV-2) Polyclonal IgG Antibody is widely used in research and diagnostic applications to study the SARS-CoV-2 virus. It can be used in techniques such as Western blotting, immunohistochemistry, immunofluorescence, and ELISA to detect and analyze the expression and localization of NSP15 in infected cells or patient samples.

By specifically targeting NSP15, this antibody enables researchers to investigate the function and role of the endoribonuclease in the viral life cycle. Understanding NSP15 is crucial for elucidating the mechanisms of viral replication, immune evasion, and pathogenesis of SARS-CoV-2.

In summary, the AffiAB® Goat anti-NSP15 (SARS-CoV-2) Polyclonal IgG Antibody is a valuable tool for scientists studying the SARS-CoV-2 virus and its key proteins. Its high specificity and sensitivity make it suitable for various research applications related to virology, immunology, and COVID-19 research.